New CGM device put to the test for accuracy in type 1 diabetes

NCT ID NCT07296276

First seen Jan 04, 2026 · Last updated May 08, 2026 · Updated 19 times

Summary

This study is testing a new continuous glucose monitor called CareSens Air 3 in 32 adults with type 1 diabetes. The goal is to see how accurately it measures blood sugar levels compared to standard lab tests. Participants will wear the device for a short time while their blood sugar is checked.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES MELLITUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Atlanta Diabetes Associates

    NOT_YET_RECRUITING

    Atlanta, Georgia, 30318, United States

    Contact Phone: •••-•••-••••

  • Diablo Clinical Research

    RECRUITING

    Walnut Creek, California, 94598, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Headlands Research AMCR

    NOT_YET_RECRUITING

    Escondido, California, 92025, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Rainier Clinical Reseach Center

    RECRUITING

    Renton, Washington, 98057, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.